Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Nutrients ; 14(16)2022 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-36014755

RESUMEN

Metabolic syndrome has become a global health care problem since it is rapidly increasing worldwide. The search for alternative natural supplements may have potential benefits for obesity and diabetes patients. Diospyros kaki fruit extract and its oligosaccharides, including gentiobiose, melibiose, and raffinose, were examined for their anti-insulin resistance and obesity-preventing effect in zebrafish larvae. The results show that D. kaki oligosaccharides improved insulin resistance and high-fat-diet-induced obesity in zebrafish larvae, evidenced by enhanced ß-cell recovery, decreased abdominal size, and reduced the lipid accumulation. The mechanism of the oligosaccharides, molecular docking, and enzyme activities of PTP1B were investigated. Three of the oligosaccharides had a binding interaction with the catalytic active sites of PTP1B, but did not show inhibitory effects in an enzyme assay. The catalytic residues of PTP1B were typically conserved and the cellular penetration of the cell membrane was necessary for the inhibitors. The results of the mechanism of action study indicate that D. kaki fruit extract and its oligosaccharides affected gene expression changes in inflammation- (TNF-α, IL-6, and IL-1ß), lipogenesis- (SREBF1 and FASN), and lipid-lowering (CPT1A)-related genes. Therefore, D. kaki fruit extract and its oligosaccharides may have a great potential for applications in metabolic syndrome drug development and dietary supplements.


Asunto(s)
Diospyros , Síndrome Metabólico , Animales , Diospyros/química , Frutas/química , Lípidos/análisis , Síndrome Metabólico/tratamiento farmacológico , Simulación del Acoplamiento Molecular , Obesidad , Oligosacáridos/análisis , Oligosacáridos/farmacología , Extractos Vegetales/análisis , Extractos Vegetales/farmacología , Pez Cebra
2.
J Nat Med ; 75(3): 520-531, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33620670

RESUMEN

Senna siamea has been used as an antidiabetic drug since antiquity. With regard to traditional Thai medicine, the use of S. siamea was described for diabetes therapy. To understand the molecular mechanism regarding insulin resistance. Pure compounds were isolated from wood extract. We studied their biological activities on insulin-resistance using an in vivo zebrafish model. We also performed an in silico study; molecular docking, and in vitro study by taking advantage of the enzyme inhibitory activities of α-glucosidase, PTP1B, and DPP-IV. Based on the preliminary investigation that ethyl acetate and ethanol extracts have potent effects against insulin resistance on zebrafish larvae, five compounds were isolated from two fractions following: resveratrol, piceatannol, dihydropiceatannol, chrysophanol, and emodin. All of the isolated compounds had anti-insulin resistance effects on zebrafish larvae. Resveratrol, piceatannol, and dihydropiceatannol also demonstrated inhibitory effects against α-glucosidase. Chrysophanol and emodin inhibited PTP1B activity, while resveratrol showed a DPP-IV inhibition effect via the molecular docking. The results of enzyme assay were similar. In conclusions, S. siamea components demonstrated effects against insulin resistance. The chemical structure displayed identical biological activity to that of the compounds. Therefore, S. siamea wood extract and their components are potential therapeutic options in the treatment of diabetes.


Asunto(s)
Hipoglucemiantes/farmacología , Resistencia a la Insulina , Extractos Vegetales/farmacología , Senna/química , Animales , Antraquinonas/farmacología , Diabetes Mellitus , Dipeptidil Peptidasa 4/metabolismo , Emodina/farmacología , Simulación del Acoplamiento Molecular , Estructura Molecular , Proteína Tirosina Fosfatasa no Receptora Tipo 1/metabolismo , Resveratrol/farmacología , Estilbenos/farmacología , Relación Estructura-Actividad , Tailandia , Madera/química , Pez Cebra/metabolismo , alfa-Glucosidasas/metabolismo
3.
Nutrients ; 12(2)2020 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-31991895

RESUMEN

Ginger (Zingiber officinale Roscoe) and its active compounds (gingerols, shogaols and paradols) have been reported as having beneficial functions for several diseases, including diabetes. In this study, we revealed that the steaming process could enhance the anti-diabetic potential of ginger. To confirm the anti-diabetic effect of steamed ginger extract (GG03), we assessed pancreatic islets impaired by alloxan in zebrafish and demonstrated anti-hyperglycemic efficacy in a mouse model. The EC50 values of ginger extract (GE) and GG03 showed that the efficacy of GG03 was greater than that of GE. In addition, LC50 values demonstrated that GG03 had lower toxicity than GE, and the comparison of the Therapeutic Index (TI) proved that GG03 is a safer functional food. Furthermore, our data showed that GG03 significantly lowered hyperglycemia in a diabetic mouse model. HPLC was performed to confirm the change in the composition of steamed ginger. Interestingly, GG03 showed a 375% increase in 1-dehydro-6-gingerdione (GD) compared with GE. GD has not yet been studied much pharmacologically. Thus, we identified the protective effects of GD in the damaged pancreatic islets of diabetic zebrafish. We further assessed whether the anti-diabetic mechanism of action of GG03 and GD involves insulin secretion. Our results suggest that GG03 and GD might stimulate insulin secretion by the closure of KATP channels in pancreatic ß-cells.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Alcoholes Grasos/farmacología , Guayacol/análogos & derivados , Hipoglucemiantes/farmacología , Células Secretoras de Insulina/efectos de los fármacos , Insulina/metabolismo , Canales KATP/antagonistas & inhibidores , Extractos Vegetales/farmacología , Zingiber officinale , Animales , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Alcoholes Grasos/aislamiento & purificación , Alcoholes Grasos/toxicidad , Zingiber officinale/química , Zingiber officinale/toxicidad , Guayacol/aislamiento & purificación , Guayacol/farmacología , Guayacol/toxicidad , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/toxicidad , Células Secretoras de Insulina/metabolismo , Células Secretoras de Insulina/patología , Canales KATP/metabolismo , Masculino , Ratones Endogámicos ICR , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Raíces de Plantas , Bloqueadores de los Canales de Potasio/farmacología , Secretagogos/farmacología , Transducción de Señal , Vapor , Pez Cebra
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA